{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "POCT",
      "SARS-CoV-2",
      "microfluidic",
      "pediatric emergency medicine"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "38257741",
  "DateCompleted": {
    "Year": "2024",
    "Month": "01",
    "Day": "24"
  },
  "DateRevised": {
    "Year": "2024",
    "Month": "01",
    "Day": "24"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "12",
        "Day": "26"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "41",
      "10.3390/v16010041"
    ],
    "Journal": {
      "ISSN": "1999-4915",
      "JournalIssue": {
        "Volume": "16",
        "Issue": "1",
        "PubDate": {
          "Year": "2023",
          "Month": "Dec",
          "Day": "26"
        }
      },
      "Title": "Viruses",
      "ISOAbbreviation": "Viruses"
    },
    "ArticleTitle": "Application of a SARS-CoV-2 Antigen Rapid Immunoassay Based on Active Microfluidic Technology in a Setting of Children and Young Adults.",
    "Abstract": {
      "AbstractText": [
        "To carry out effective and quick identification of SARS-CoV-2 from nasopharyngeal swabs and contain outbreaks, reliable and rapid tools are needed. Herein, we compared a rapid antigen test based on active microfluidic technology to an RT-qPCR assay in pediatric and young adult patients admitted to the Pediatric Emergency Unit of a Children's Hospital. Nasopharyngeal swabs collected from patients with suspected COVID-19 disease and from those without COVID-19 related symptoms, but requiring hospitalization, were performed with both antigen test and RT-qPCR assays. We included 375 patients with a median age of 5 years in the study, with an estimated overall prevalence of 7.2%. Overall, we observed a specificity of 97.4% (95% CI: 94.9-98.7) and a sensitivity of 66.6% (95% CI: 46.0-82.7) with a positive likelihood ratio (LR+) of 25.8 (95% CI: 12.8-51.8). In the subgroup of symptomatic patients, the specificity and the sensitivity were 95.2% (95% CI: 89.4-98.0) and 80.0% (95% CI: 44.2-96.5) respectively; LR+ was 16.6 (95% CI: 7.19-38.6). In the asymptomatic subset, the performance showed a specificity of 98.7% (95% CI: 95.8-99.7), a sensitivity of 58.8% (95% CI: 33.5-80.6), and an LR+ of 43.7 (95% CI: 13.3-144.0). Compared to RT-qPCR, the new microfluidic-based antigen test showed higher specificity (>95%) in the pediatric population, thus representing a suitable point-of-care testing (POCT) in a clinical setting with low prevalence of COVID-19."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-8689-7028"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Microbiology and Virology Laboratory, A.O. \"SS. Antonio e Biagio e C. Arrigo\", Via Venezia 16, 15121 Alessandria, Italy."
          }
        ],
        "LastName": "Leli",
        "ForeName": "Christian",
        "Initials": "C"
      },
      {
        "Identifier": [
          "0000-0003-0029-5673"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Microbiology and Virology Laboratory, A.O. \"SS. Antonio e Biagio e C. Arrigo\", Via Venezia 16, 15121 Alessandria, Italy."
          }
        ],
        "LastName": "Ferrara",
        "ForeName": "Lidia",
        "Initials": "L"
      },
      {
        "Identifier": [
          "0000-0002-6337-5729"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Microbiology and Virology Laboratory, A.O. \"SS. Antonio e Biagio e C. Arrigo\", Via Venezia 16, 15121 Alessandria, Italy."
          }
        ],
        "LastName": "Bottino",
        "ForeName": "Paolo",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Microbiology and Virology Laboratory, A.O. \"SS. Antonio e Biagio e C. Arrigo\", Via Venezia 16, 15121 Alessandria, Italy."
          }
        ],
        "LastName": "Bara",
        "ForeName": "Cristina",
        "Initials": "C"
      },
      {
        "Identifier": [
          "0000-0001-9508-3037"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research and Innovation Department (DAIRI), A.O. \"SS. Antonio e Biagio e C. Arrigo\", Via Venezia 16, 15121 Alessandria, Italy."
          }
        ],
        "LastName": "Megna",
        "ForeName": "Iacopo",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research and Innovation Department (DAIRI), A.O. \"SS. Antonio e Biagio e C. Arrigo\", Via Venezia 16, 15121 Alessandria, Italy."
          }
        ],
        "LastName": "Penpa",
        "ForeName": "Serena",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pediatric and Pediatric Emergency Unit, A.O. \"SS. Antonio e Biagio e C. Arrigo\", Via Venezia 16, 15121 Alessandria, Italy."
          }
        ],
        "LastName": "Felici",
        "ForeName": "Enrico",
        "Initials": "E"
      },
      {
        "Identifier": [
          "0000-0002-1904-7277"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research and Innovation Department (DAIRI), A.O. \"SS. Antonio e Biagio e C. Arrigo\", Via Venezia 16, 15121 Alessandria, Italy."
          }
        ],
        "LastName": "Maconi",
        "ForeName": "Antonio",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Microbiology and Virology Laboratory, A.O. \"SS. Antonio e Biagio e C. Arrigo\", Via Venezia 16, 15121 Alessandria, Italy."
          }
        ],
        "LastName": "Rocchetti",
        "ForeName": "Andrea",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Viruses",
    "NlmUniqueID": "101509722",
    "ISSNLinking": "1999-4915"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antigens, Viral"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Microfluidics"
    },
    {
      "QualifierName": [
        "diagnosis",
        "epidemiology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Antigens, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Technology"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunoassay"
    }
  ]
}